Simply stick with statins for treating ACS

As a general rule it is overkill to prescribe intensive cholesterol-lowering treatment to patients with acute coronary syndrome and dyslipidemia, a Japanese researcher argues.

Professor Nobuhisa Hagiwara says that for the most part, statin therapy alone is sufficient to improve cardiovascular outcomes in ACS patients.

The results show that a combination of pitavastatin with ezetimbe does not improve